Hypothyroidism in the patient with cancer: How much thyroid supplementation is "safe"? [5]

Archives of Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 6, 2007, Pages 625-626

  Hercbergs, Aleck ^a   Davis, Paul ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; LIOTHYRONINE; THYROXINE;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER SURVIVAL; CLINICAL STUDY; HEAD AND NECK CANCER; HUMAN; HYPOTHYROIDISM; LETTER;

EID: 34250831480     PISSN: 08864470     EISSN: 08864470     Source Type: Journal    
DOI: 10.1001/archotol.133.6.625-c     Document Type: Letter

References (6)

1. Nelson M, Hercbergs A, Rybicky L, Strome M. Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006;132:1041-1046.
2. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-238.
3. Bergh JJ, Lin H-Y, Lansing L, et al. Integrin alphaVbeta3 contains a cell surface receptor site for thyroid hormone that is linked to activation of mitogen-activated protein kinase and induction of angiogenesis. Endocrinology. 2005;146:2864-2871.
4. Davis FB, Tang H-Y, Shih A, et al. Acting via a cell surface receptor, thyroid hormone is a growth factor for glioma cells. Cancer Res. 2006;66:7270-7275.
5. Hercbergs AA, Goyal LK, Suh JH, et al. Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high-grade glioma: a phase 1-2 study. Anticancer Res. 2003;23(1B):617-626.
6. Cristofanilli M, Yamamura Y, Kau SW, et al. Thyroid hormone and breast cancer: primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cancer. 2005;103:1122-1128.